Evidence map›Paper›PMID 40660185›Full record

ArticleBMC nephrology2025

Continuous renal replacement therapy (CRRT) program initiation in PICU of a resource limited setting: a retrospective analysis of challenges and outcomes.

Jerin C Sekhar, Karthi Nallasamy, Muralidharan Jayashree, Manjinder Singh Randhawa, Namita Ravikumar, Sudeep K C, Suresh Kumar Angurana, Arun Bansal

Abstract read
In one paragraph

Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jerin C SekharDivision of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Karthi NallasamyDivision of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. ny.karthi@gmail.com.
Muralidharan JayashreeDivision of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Manjinder Singh RandhawaDivision of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Namita RavikumarDepartment of Pediatrics, Ramaiah Medical College, Bengaluru, Karnataka, India.
Sudeep K CDepartment of Pediatrics, Maharajgunj Medical Campus (MMC), Tribhuvan University Teaching Hospital (TUTH), Kathmandu, Nepal.
Suresh Kumar AnguranaDivision of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Arun BansalDivision of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundContinuous Renal Replacement Therapy (CRRT) is emerging as an essential component of organ support in critically ill children. In low- and middle- income countries (LMIC), limited resources, lack of technical support, cost, and administrative issues are major barriers in initiating and sustaining a CRRT program.

methodsA core team, comprising a consultant and two pediatric intensive care fellows, was assigned additional responsibility of initiating and sustaining a CRRT program in the PICU of a tertiary care teaching and referral hospital. We retrospectively reviewed the data from initiation in February 2019 till May 2023 to understand the indications, prescription details, challenges, and their relation to outcomes.

resultsDuring this period, 52 children with mean (SD) age of 7.6 (3.2) years and median (IQR) weight of 20 (17, 30) kg underwent CRRT in 71 sessions. The mean PRISM-III score was 18 (5.2), with 98.1% having multiorgan dysfunction at CRRT initiation. Acute kidney injury (53.8%), hyperammonemia (21.2%), and a combination of both (17.3%) were common indications. Continuous venovenous hemodiafiltration was the most used modality (61.5%). Median CRRT duration was 36 (20.3, 58) hours. Filter usage averaged 1.4 per patient with a median life of 35 (17, 48) hours, improving from 24 to 36 h over time. Filter clotting (33.8%), access flow issues (7%), and hemodynamic instability (4.2%) were complications encountered. Survival to discharge was 25%, with serum lactate [Formula: see text]3 mmol/L at CRRT initiation being an independent predictor of mortality (adjusted OR 6.1, 95% CI: 1.1-34.9; P = 0.04). Major challenges faced in our program included the SARS-CoV-2 pandemic, non-availability of technical support, and out-of-pocket expenses. These were circumvented by involvement of fellows and nurses, training them with internal and external experts, and mobilizing resources from governmental and non-governmental organizations.

conclusionInitiating a CRRT program in LMICs is feasible despite challenges. Creating a team with members willing to shoulder additional responsibility and training them gave impetus to our program. Tapping governmental and non-governmental support helped us circumvent financial challenges. However, in a resource limited setting, sustainability requires in-house technical and financial support. Survival to discharge was 25%, with hyperlactatemia at CRRT initiation predicting mortality.

Indexed as

Acute Kidney InjuryContinuous Renal Replacement TherapyIntensive Care Units, PediatricChildChild, PreschoolCritical IllnessDeveloping CountriesFemaleHumansInfantMaleRetrospective StudiesTreatment OutcomeAcute kidney injuryFilter lifeFinancial constraintsHealthcare delivery challengesHuman resource constraintsLow- and middle-income countriesMultiorgan dysfunctionSustainability

Identifiers

PMID40660185
PMCPMC12257853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.